Compare ADMA Biologics Inc (ADMA) vs NetApp Inc. (NTAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs NetApp Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while NetApp Inc. trades at $199.43 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 17.5× ADMA Biologics Inc's market cap, and NetApp Inc. pays a 1.05% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | NTAP | |
|---|---|---|
Market Cap | $2.22B | $38.95B |
Sector | Health | Technology |
52-Week High | $20.38 | $198.72 |
52-Week Low | $7.60 | $94.11 |
Enterprise Value | $2.29B | $38.10B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About NetApp Inc.
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →
